Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 16, 2006Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
Boston Scientific Corporation (NYSE: BSX) announced today that it has received indication extensions to the European CE mark for its TAXUS®...
-
May 15, 2006
Boston Scientific Corporation (NYSE: BSX) today announced physician communications related to products in its Cardiac Rhythm Management (CRM) Group,...
-
May 11, 2006
Boston Scientific Corporation (NYSE: BSX) announced that the U.S. District Court in Delaware issued a ruling upholding two jury decisions in a...
-
May 11, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that Donald S. Baim, M.D., will be joining the Company as Executive Vice President, Chief...
-
May 10, 2006Boston Scientific is the exclusive U.S. distributor of this product for a new treatment option for female stress urinary incontinence
Boston Scientific Corporation (NYSE: BSX) and BioForm Medical, Inc. today announced United States Food and Drug Administration...
-
May 9, 2006Results to include nine-month data on TAXUS® Liberte™
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on...
-
May 4, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that it has filed a lawsuit in Ireland against Conor Medsystems Ireland Ltd. (NASDAQ:...
-
May 3, 2006
Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI)(NASDAQ: TSX:)(NASDAQ: ANP) announced...
-
May 1, 2006Endoscopic vessel harvesting speeds recovery and reduces pain and scarring; new products offer clinicians more choices to improve patient outcomes
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of the VASOVIEW® 7 Endoscopic Vessel Harvesting System and VASOVIEW®...
-
Apr 28, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...
-
Apr 28, 2006
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 2-3 in...
-
Apr 26, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it plans to implement all the recommendations contained in a draft report by the...
-
Apr 26, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that the company's Board of Directors elected Kristina M. Johnson, Ph.D. and Nancy-Ann...
-
Apr 21, 2006
Boston Scientific Corporation (NYSE: BSX) announced today that it has increased the interest rate payable on its $400 million 5.50 percent senior...
-
Apr 21, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a...
-
Apr 20, 2006Transaction scheduled to close tomorrow
Boston Scientific Corporation (NYSE: BSX) today announced it has received antitrust approval from the U.S. Federal Trade Commission (FTC) for its...
-
Apr 18, 2006
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2006. Highlights: * Record net...
-
Apr 17, 2006New study seeks to define potential of Precision™ system to treat large population of U.S. migraine sufferers who don't respond adequately to current therapies
Boston Scientific Corporation (NYSE: BSX) today announced that the first patient in the PRISM (Precision® Implantable Stimulator for Migraine)...
-
Apr 11, 2006
Boston Scientific Corporation (NYSE: BSX) today announced that it has received antitrust clearance from the European Commission regarding its...
-
Apr 7, 2006
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2006...
-
Apr 5, 2006Agreement subject to approval by FTC Commissioners
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement containing consent orders with the staff of the...
-
Apr 3, 2006
Boston Scientific Corporation (NYSE: BSX) today announced the newest addition to its broad portfolio of vascular access products with the launch of...
-
Mar 31, 2006
Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the shareholders of each...